401 related articles for article (PubMed ID: 30661942)
1. Relationship between intestinal microbial dysbiosis and primary liver cancer.
Zhang L; Wu YN; Chen T; Ren CH; Li X; Liu GX
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):149-157. PubMed ID: 30661942
[TBL] [Abstract][Full Text] [Related]
2. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
4. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.
Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722100
[TBL] [Abstract][Full Text] [Related]
5. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
[TBL] [Abstract][Full Text] [Related]
6. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.
Wu Z; Zhou H; Liu D; Deng F
Front Cell Infect Microbiol; 2023; 13():1218552. PubMed ID: 37483387
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.
Sun X; Chi X; Zhao Y; Liu S; Xing H
J Diabetes Res; 2022; 2022():1826181. PubMed ID: 35601017
[TBL] [Abstract][Full Text] [Related]
9. Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients.
Midori Y; Nosaka T; Hiramatsu K; Akazawa Y; Tanaka T; Takahashi K; Naito T; Matsuda H; Ohtani M; Nakamoto Y
Front Cell Infect Microbiol; 2024; 14():1371429. PubMed ID: 38650735
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota dysbiosis play a role in pathogenesis of patients with primary immune thrombocytopenia.
Liu C; Cheng L; Ji L; Li F; Zhan Y; Wu B; Ke Y; Chen P; Hua F; Yuan L; Min Z; Sun L; Chen H; Cheng Y
Thromb Res; 2020 Jun; 190():11-19. PubMed ID: 32272276
[TBL] [Abstract][Full Text] [Related]
11. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease.
Raj AS; Shanahan ER; Tran CD; Bhat P; Fletcher LM; Vesey DA; Morrison M; Holtmann G; Macdonald GA
Clin Transl Gastroenterol; 2019 Aug; 10(8):e00068. PubMed ID: 31373933
[TBL] [Abstract][Full Text] [Related]
14. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
[TBL] [Abstract][Full Text] [Related]
16. Gut Dysbiosis Associated With Hepatitis C Virus Infection.
Inoue T; Nakayama J; Moriya K; Kawaratani H; Momoda R; Ito K; Iio E; Nojiri S; Fujiwara K; Yoneda M; Yoshiji H; Tanaka Y
Clin Infect Dis; 2018 Aug; 67(6):869-877. PubMed ID: 29718124
[TBL] [Abstract][Full Text] [Related]
17. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.
Bajaj JS; Fagan A; Sikaroodi M; White MB; Sterling RK; Gilles H; Heuman D; Stravitz RT; Matherly SC; Siddiqui MS; Puri P; Sanyal AJ; Luketic V; John B; Fuchs M; Ahluwalia V; Gillevet PM
Liver Transpl; 2017 Jul; 23(7):907-914. PubMed ID: 28240840
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of gut microbiota was closely associated with psoriasis.
Huang L; Gao R; Yu N; Zhu Y; Ding Y; Qin H
Sci China Life Sci; 2019 Jun; 62(6):807-815. PubMed ID: 30264198
[TBL] [Abstract][Full Text] [Related]
20. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]